TipRanks
Advertisement
Advertisement

MTVA Stock Latest News

Analyst Maintains Buy Rating on MetaVia (MTVA) with Unchanged $8 Price Target, Citing Strong Early Obesity Data for DA-1726
RatingsAnalyst Maintains Buy Rating on MetaVia (MTVA) with Unchanged $8 Price Target, Citing Strong Early Obesity Data for DA-1726
22d ago
MTVA
MetaVia Highlights DA-1726 Preclinical Data for Obesity Program
PremiumCompany Announcements
MetaVia Highlights DA-1726 Preclinical Data for Obesity Program
23d ago
8K
MTVA
MetaVia reports results from DA-1726-derived radioactivity study
PremiumThe Fly
MetaVia reports results from DA-1726-derived radioactivity study
23d ago
MTVA
MetaVia (MTVA): Buy Rating Reiterated as DA-1726 Nears Key 4Q26 Data; $20 Price Target Reaffirmed
PremiumRatings
MetaVia (MTVA): Buy Rating Reiterated as DA-1726 Nears Key 4Q26 Data; $20 Price Target Reaffirmed
2M ago
MTVA
MetaVia Advances DA-1726 and Vanoglipel in Q2 Update
PremiumCompany Announcements
MetaVia Advances DA-1726 and Vanoglipel in Q2 Update
2M ago
8K
MTVA
Analyst Maintains Buy on MetaVia, Keeps $8 Price Target as DA-1726 Next-Gen Obesity Data Advances
PremiumRatingsAnalyst Maintains Buy on MetaVia, Keeps $8 Price Target as DA-1726 Next-Gen Obesity Data Advances
3M ago
MTVA
Analyst Reaffirms Buy on MTVA as DA-1726 Data De-Risk Obesity and MASH Opportunity; Price Target Maintained at $20
Premium
Ratings
Analyst Reaffirms Buy on MTVA as DA-1726 Data De-Risk Obesity and MASH Opportunity; Price Target Maintained at $20
3M ago
MTVA
MetaVia Advances DA-1726 Obesity Trial to Top Doses
Premium
Company Announcements
MetaVia Advances DA-1726 Obesity Trial to Top Doses
3M ago
8K
MTVA
MetaVia announces completion of dose titration in Phase 1 study of DA-1726
PremiumThe Fly
MetaVia announces completion of dose titration in Phase 1 study of DA-1726
3M ago
MTVA
MetaVia Announces $4 Million At-The-Market Stock Offering
PremiumCompany Announcements
MetaVia Announces $4 Million At-The-Market Stock Offering
3M ago
8K
MTVA
MetaVia: Buy Rating Reiterated as Synergistic Cardiometabolic Pipeline Supports Unchanged $8 Price Target
PremiumRatings
MetaVia: Buy Rating Reiterated as Synergistic Cardiometabolic Pipeline Supports Unchanged $8 Price Target
4M ago
MTVA
MetaVia Shareholders Approve Equity Plan and Reverse Split
PremiumCompany Announcements
MetaVia Shareholders Approve Equity Plan and Reverse Split
4M ago
8K
MTVA
MetaVia highlights obesity and metabolic pipeline advancements
PremiumCompany AnnouncementsMetaVia highlights obesity and metabolic pipeline advancements
4M ago
8K
MTVA
MetaVia presents data at ADA supporting DA-1726, vanoglipel
Premium
The Fly
MetaVia presents data at ADA supporting DA-1726, vanoglipel
4M ago
MTVA
Fein Reiterates Buy on MetaVia as New Phase 1 Liver Data De-Risk DA-1726 and Support Unchanged $20 Price Target
Premium
Ratings
Fein Reiterates Buy on MetaVia as New Phase 1 Liver Data De-Risk DA-1726 and Support Unchanged $20 Price Target
4M ago
MTVA
MetaVia’s DA-1726 shows efficacy in obesity and MASH presentations
PremiumThe Fly
MetaVia’s DA-1726 shows efficacy in obesity and MASH presentations
4M ago
MTVA
MetaVia highlights promising Phase 1 obesity drug data
PremiumCompany Announcements
MetaVia highlights promising Phase 1 obesity drug data
4M ago
8K
MTVA
3 Penny Stocks to Watch Now, 5/21/26
PremiumMarket News
3 Penny Stocks to Watch Now, 5/21/26
4M ago
HCWB
MTVA
Analyst Reiterates Buy on MetaVia, Maintains $8 Price Target Amid Promising Metabolic Pipeline and Upcoming Data Catalysts
PremiumRatings
Analyst Reiterates Buy on MetaVia, Maintains $8 Price Target Amid Promising Metabolic Pipeline and Upcoming Data Catalysts
4M ago
MTVA
Fein Reiterates Buy on MetaVia, Keeps DA-1726-Driven Price Target Unchanged at $20
PremiumRatingsFein Reiterates Buy on MetaVia, Keeps DA-1726-Driven Price Target Unchanged at $20
5M ago
MTVA
MetaVia Showcases Key Cardiometabolic Data at ADA 2026
Premium
Company Announcements
MetaVia Showcases Key Cardiometabolic Data at ADA 2026
5M ago
8K
MTVA
MetaVia Highlights Strong DA-1726 Phase 1 Weight-Loss Data
Premium
Company Announcements
MetaVia Highlights Strong DA-1726 Phase 1 Weight-Loss Data
5M ago
8K
MTVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >